The Journal of clinical psychiatry
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.
Duloxetine hydrochloride, a dual reuptake inhibitor of serotonin and norepinephrine, was evaluated for therapeutic efficacy and safety/tolerability in the treatment of major depression. ⋯ These data indicate that duloxetine is efficacious for the treatment of major depressive disorder and is well tolerated and safe.